CN103848767A - 一种芳基硫醚类化合物的合成方法 - Google Patents

一种芳基硫醚类化合物的合成方法 Download PDF

Info

Publication number
CN103848767A
CN103848767A CN201410041032.6A CN201410041032A CN103848767A CN 103848767 A CN103848767 A CN 103848767A CN 201410041032 A CN201410041032 A CN 201410041032A CN 103848767 A CN103848767 A CN 103848767A
Authority
CN
China
Prior art keywords
reaction
aryl
dppf
ethyl acetate
cdcl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410041032.6A
Other languages
English (en)
Other versions
CN103848767B (zh
Inventor
姜雪峰
乔宗君
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
East China Normal University
Original Assignee
East China Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by East China Normal University filed Critical East China Normal University
Priority to CN201410041032.6A priority Critical patent/CN103848767B/zh
Publication of CN103848767A publication Critical patent/CN103848767A/zh
Application granted granted Critical
Publication of CN103848767B publication Critical patent/CN103848767B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种式(3)所示的芳基硫醚类化合物的合成方法,是在反应溶剂中,以芳基碘化物或芳基三氟甲烷磺酸酯类衍生物,与卤代烷烃为反应原料,以Na2S2O3为硫化试剂,在金属钯催化剂作用下,反应得到多取代的芳基硫醚类化合物。本发明反应条件温和,原料易得价廉,反应操作简单,产率较高,为很多天然产物和药物的合成提供关键的骨架结构,可以广泛适用于工业化规模生产。

Description

一种芳基硫醚类化合物的合成方法
技术领域
本发明属于有机化合物工艺应用技术领域,具体涉及一种制备芳基硫醚类化合物的合成方法。 
背景技术
芳基硫醚化合物(即分子中含有C—S键的有机化合物)是一类非常重要的化合物,它广泛存在于各类药物化学(如下所示)、材料化学和食物化学中,因此,从一些结构简单、商业上可以大量获得的化合物上构建C—S键显得尤为重要。 
Figure BDA0000462974950000011
合成芳基硫醚类化合物的传统方法主要是通过硫醇或者苯硫酚类化合物来制备。但是此方法中,硫醇及苯硫酚需要预先制备,底物的适应性不够广泛,不仅味道较大,污染严重,且很容易被氧化,使此方法的应用受到制约。 
发明内容
本发明克服现有技术的以上缺陷,首次创新地提出了一种简单高效制备芳基硫醚类化合物的新方法,通过使用金属钯催化剂,通过交叉偶联的方式,以Na2S2O3为硫化试剂,可以高效地实现反应的转化。 
所述反应过程如反应式(I)所示。 
Figure 45696DEST_PATH_GDA0000487973730000021
如以上反应式(I)所示,本发明利用芳基碘化物或芳基三氟甲烷磺酸酯类衍生物(底物1),卤代烷烃(底物2)和Na2S2O3作为起始原料,在金属钯催化剂的作用下,在反应溶剂中进行反应,合成如式(3)所示的芳基硫醚类化合物。 
本发明中,R是苯环、杂环、取代苯环、或取代杂环;R’是氢、卤素、杂原子、烷基、杂环;X是I、Br、Cl、OTf;Y是Cl。优选地,R是取代苯环,取代杂环。X是I、OTf。Y是Cl。R’是氢、杂原子、烷基、杂环。本发明中,R、R’、X、Y包括但不仅仅局限于上述基团,例如,R还可以是多取代基,取代的芳环和杂环、各类侧链。 
本发明中,所述起始原料如式(1)所示的芳基碘化物或芳基三氟甲烷磺酸酯类衍生物(底物1)和硫化试剂Na2S2O3的用量比例为1∶1-1∶5。优选地,两者用量比例为1∶5。 
所述起始原料如式(1)所示的芳基碘化物或芳基三氟甲烷磺酸酯类衍生物和卤化物(底物2)用量比例为11-115。优选地,两者用量比例为115。 
本发明中,以Na2S2O3为硫化试剂。 
本发明中,所述钯催化剂是Pd(OAc)2、PdCl2、Pd(TFA)2、Pd(dba)2、Pd2(dba)3、PdCl2(PPh3)2、PdCl2(dppf)或PdCl2(dppp)。优选地,所述钯催化剂是PdCl2(dppf)。所述催化剂的用量为原料芳基碘化物或芳基三氟甲烷磺酸酯类衍生物(底物1)的1-10mol%。优选地,所述催化剂用量为10mol%。 
本发明中,所述配体是PPh3、PtBu3、三环己基膦、三呋喃基膦、dppm(1,1-双(二苯基膦)甲烷)、dppe[1,2-双(二苯基膦)乙烷]、dppp[1,3-双(二苯基膦)丙烷]、dppb[1,4-双(二苯膦基)丁烷]、dppf[1,1′-双(二苯基膦)二茂铁]或binap[2,2′-双二苯膦基-1,1′-联萘]。优选地,所述配体是dppf[1,1′-双(二苯基膦)二茂铁]。所述配体用量为芳基碘化物或芳基三氟甲烷磺酸酯类衍生物(底物1)的1-5mo1%。优选地,所述配体用量为5mol%。 
本发明中,所述添加剂为水、乙醇、甲醇、乙二醇或环己二醇。优选地,所述添加剂为乙二醇。所述添加剂包括但不局限于以上,还可以是水。 
本发明中,所述碱为K2CO3、Cs2CO3、K3PO4、TEA(三乙胺)或DMAP(4,4-二甲氨基吡啶)。优选地,所述碱为Cs2CO3。所述碱包括但不局限于以上,还可以是NaOH,KOH,Na2CO3,DBU(二环脒)。 
本发明中,所述反应溶剂是甲苯、DMA、1,2-二氯乙烷、THF或乙腈。优选地,所述溶剂为DMSO。所述反应溶剂包括但不局限于以上,还可以是氯苯、1,4-二氧六环、DMF。 
本发明中,所述合成反应是在120-150℃温度下进行。优选地,是在120℃温度下进行反应。 
在一个具体实例中,本发明合成反应是在反应瓶A中,将芳基碘化物或芳基三氟甲烷磺酸酯类衍生物(底物1,X mmol),卤化物(底物2,Ymmol)溶解在Z mL反应溶剂中,室温下,依次加入硫化试剂Na282O3(U mmol),催化剂PdCl2(dppf)(V mmol%),配体dppf(Wmmol%),添加剂(P mmol),碱Cs2CO3(Q mol%)。反应在80-120℃下反应10个小时。用TLC检测反应进程。反应完毕后,直接加硅胶,旋干柱层析,分离得到目标产物3。 
本发明还提出了按照本发明上述合成方法制备得到的如式(3)所示的芳基硫醚类化合物。 
本发明优点包括:本发明合成方法所使用的各原料非常简单,均为工业化商品,简单易得,来源广泛,并且性能非常稳定,不需要特殊保存条件。本发明所用的各种金属催化剂和配体也都是常用的商品化试剂,非常稳定。使用无色无味的硫代硫酸钠作为硫化试剂,具有成本低、产率高、工艺简、污染少的特色,完全可适用于大规模生产。合成芳基硫醚类化合物的传统的方法一般是使用硫醇或者硫酚来实现。但是,由于其味道较大,容易被氧化,后处理难,污染严重,对工业化生产造成很大的限制。本发明以容易制备的芳基碘化物或芳基三氟甲烷磺酸酯类衍生物为反应原料,以无色无味的Na2S2O3盐做为硫化试剂,在金属钯催化剂作用下,反应得到取代的芳基硫醚类化合物。反应操作比较简单,反应条件温和,产率较高,适合大规模工业化生产。 
具体实施方式
结合以下具体实施例,对本发明作进一步的详细说明,本发明的保护内容不局限于以下实施例。在不背离发明构思的精神和范围下,本领域技术人员能够想到的变化和优点都被包括在本发明中,并且以所附的权利要求书为保护范围。实施本发明的过程、条件、试剂、实验方法等,除以下专门提及的内容之外,均为本领域的普遍知识和公知常识,本发明没有特别限制内容。以下实施例所给出的数据包括具体操作和反应条件及产物。产物纯度通过核磁鉴定。 
实施例1 
正丁基(4-乙酰基苯基)硫醚的合成: 
Figure BDA0000462974950000041
在氮气氛围下,于25mL的封管中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),dppf(0.01mmol,5.6mg),Cs2CO3(0.3mmol,l95.0mg),Na282O3·5H2O(0.5mmol,248.0mg),CH3CN(4.0mL)and H2O(0.2mL),将反应体系加热至150℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(45%)。Rf=0.35(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3)∶δ7.77(d,J=8.4Hz,2H),7.21(d,J=8.4Hz,2H),2.91(t,J=7.2Hz,2H),2.48(s,3H),1.64-1.57(m,2H),1.45-1.36(m,2H),0.87(t,J=7.2Hz,3H); 13C NMR(100MHz,CDCl3)∶δ197.1,144.9,133.6,128.6,126.1,31.5,30.7,26.3,21.9,13.5;IR(neat)2956,1679,1490,1463,1428,1357,1265,1185,1011,817cm-1;HRMS(EI)计算值C12H16OS208.0922,实际值208.0921. 
实施例2 
正丁基(4-乙酰基苯基)硫醚的合成: 
在氮气氛围下,于25mL的封管中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),Pd(dba)2(0.02mmol,l1.5mg),dppp(0.03mmol,12.2mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),CH3CN(4.0mL)and H2O(0.2mL).将反应体系加热至150℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(22%)。产物分析数据同实例一。 
实施例3 
正丁基(4-乙酰基苯基)硫醚的合成: 
Figure BDA0000462974950000051
在氮气氛围下,于25mL的封管中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),CH3CN(4.0mL)and H2O(0.2mL).将反应体系加热至150℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(35%)。产物分析数据同实例一。 
实施例4 
正丁基(4-乙酰基苯基)硫醚的合成: 
在氮气氛围下,于25mL的封管中加入底物2bm(0.2mmol,49.2mg),l-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),dppe(0.01mmol,3.9mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),CH3CN(4.0mL)and H2O(0.2mL)。将反应体系加热至150℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(31%)。产物分析数据同实例一。 
实施例5 
正丁基(4-乙酰基苯基)硫醚的合成: 
Figure BDA0000462974950000053
在氮气氛围下,于25mL的封管中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),dppp(0.01mmol,4.1mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),CH3CN(4.0mL)and H2O(0.2mL)。将反应体系加热至150℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(46%)。产物分析数据同实例一。 
实施例6 
正丁基(4-乙酰基苯基)硫醚的合成: 
Figure BDA0000462974950000061
在氮气氛围下,于25mL的封管中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),dppb(0.01mmol,4.3mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),CH3CN(4.0mL)and H2O(0.2mL)。将反应体系加热至150℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(29%)。产物分析数据同实例一。 
实施例7 
正丁基(4-乙酰基苯基)硫醚的合成: 
Figure BDA0000462974950000062
在氮气氛围下,于25mL的试管反应器中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),dppf(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMF(4.0mL)。将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用 乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(46%)。产物分析数据同实例一。 
实施例8 
正丁基(4-乙酰基苯基)硫醚的合成: 
Figure BDA0000462974950000071
在氮气氛围下,于25mL的试管反应器中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),dppf(0.01mmol,5.6mg),Cs2C03(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)。将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(47%)。产物分析数据同实例一。 
实施例9 
正丁基(4-乙酰基苯基)硫醚的合成: 
Figure BDA0000462974950000072
在氮气氛围下,于25mL的试管反应器中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),dppf(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMF(4.0mL),glycol(0.2mL)。将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(57%)。产物分析数据同实例一。 
实施例10 
正丁基(4-乙酰基苯基)硫醚的合成: 
Figure BDA0000462974950000081
在氮气氛围下,于25mL的试管反应器中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),dppf(0.01mmol,5.6mg),Cs2C03(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL),glycol(0.2mL)。将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(63%)。产物分析数据同实例一。 
实施例11 
正丁基(4-乙酰基苯基)硫醚的合成: 
Figure BDA0000462974950000082
在氮气氛围下,于25mL的试管反应器中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),dppf(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL),glycol(0.4mL)。将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(40%)。产物分析数据同实例一。 
实施例12 
正丁基(4-乙酰基苯基)硫醚的合成: 
Figure BDA0000462974950000091
在氮气氛围下,于25mL的试管反应器中加入底物2bm(0.2mmol,49.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),dppf(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL),glycol(0.1mL)。将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2b(88%)。产物分析数据同实例一。 
实施例13 
正丁基(4-醛基苯基)硫醚的合成: 
Figure BDA0000462974950000092
在氮气氛围下,于25mL的试管反应器中加入底物2am(0.2mmol,46.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2a(86%)。Rf=0.70(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3)∶δ9.91(s,1H),7.75(d,J=8.4Hz,2H),7.34(d,J=8.0Hz,2H),3.00(t,J=7.6Hz,2H),1.73-1.65(m,2H),1.53-1.46(m,2H),0.95(t,J=7.6Hz,3H);13C NMR(400MHz,CDCl3)∶δ191.2,147.1,133.1,130.0,126.3,31.5,30.7,22.0,13.6;IR(neat)2956,2930,2872,1591,1489,1409,1304,1214,812,684cm-1;HRMS(EI)计算值C11H14OS194.0765,实际值194.0767. 
实施例14 
正丁基(4-甲酸乙酯苯基)硫醚的合成: 
Figure BDA0000462974950000101
在氮气氛围下,于25mL的试管反应器中加入底物2cm(0.2mmol,55.2mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dpPf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2c(55%)。Rf=0.60(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ7.85(d,J=8.4Hz,2H),7.20(d,J=8.4Hz,2H),4.28(q,J=7.2Hz,14.4Hz,2H),1.63-1.56(m,2H),1.42-1.35(m,2H),1.30(t,J=7.2Hz,3H),0.86(t,J=7.6Hz,3H);13C NMR(400MHz,CDCl3):δ166.3,144.2,129.8,126.9,126.3,60.8,31.7,30.8,22.0,14.3,13.6.IR(neat)2959,2872,1715,1595,1464,1367,1274,1180,1017,846cm-1;HRMS(EI)计算值C13H18O2S238.1028,实际值238.1030. 
实施例15 
正丁基(2-氰基苯基)硫醚的合成: 
Figure BDA0000462974950000102
在氮气氛围下,于25mL的试管反应器中加入底物2dm(0.2mmol,45.8mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2d(82%)。Rf=0.40(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ7.60-7.57(m,1H),7.51-7.47(m,1H),7.40-7.38(m,1H),7.24-7.20(m,1H),3.00(t,J=7.6Hz,2H),1.69-1.62(m,2H),1.51-1.42(m,2H),0.92(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ142.1,133.5.132.7,128.5,125.6,117.1,113.2,33.1,30.7,21.8,13.5;IR(neat)2958,2222,1463,1434,1195,1167,1068,755,716 cm-1;HRMS(EI)计算值C11H13NS191.0769,实际值191.0768. 
实施例16 
正丁基(3-氰基苯基)硫醚的合成: 
Figure BDA0000462974950000111
在氮气氛围下,于25mL的试管反应器中加入底物2em(0.2mmol,45.8mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dpPf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2e(80%)。Rf=0.50(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ7.52(s,1H),7.50-7.46(m,1H),7.43-7.40(m,1H),7.37-7.33(m,1H),2.95(t,J=7.2Hz,2H),1.68-1.61(m,2H),1.51-1.42(m,2H),0.94(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ139.8,132.2,130.1,129.3,128.7,118.5,113.1,32.6,30.8,21.9,13.6;IR(neat)2958,2230,1586,1468,1436,1405,1222,1197,1089,875,790,681cm-1;HRMS(EI)计算值C11H13NS191.0769,实际值191.0770. 
实施例17 
正丁基(4-氰基苯基)硫醚的合成: 
Figure BDA0000462974950000112
在氮气氛围下,于25mL的试管反应器中加入底物2fm(0.2mmol,45.8mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水 溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2f(63%)。Rf=0.50(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ7.43(d,J=8.8Hz,2H),7.21(d,J=8.4Hz,2H),2.89(t,J=7.2Hz,2H),1.64-1.56(m,2H),1.44-1.35(m,2H),0.87(t,J=7.2Hz,3H); 13C NMR(400MHz,CDCl3):δ145.2,132.1,126.5,118.9,107.8,31.5,30.5,21.9,13.5;IR(neat)2957,2225,1594,1486,1465,1437,1243,1179,1015,819em-1;HRMS(EI)计算值C11H13NS191.0769,实际值191.0770. 
实施例18 
正丁基(2-硝基苯基)硫醚的合成: 
Figure BDA0000462974950000121
在氮气氛围下,于25mL的试管反应器中加入底物2gm(0.2mmol,49.8mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2g(55%)。Rf=0.40(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ8.21-8.19(m,1H),7.57-7.52(m,1H),7.42-7.40(m,1H),7.26-7.22(m,1H),2.96(t,J=7.6Hz,2H),1.75-1.71(m,2H),1.58-1.51(m,2H),0.97(t,J=7.2,3H);13C NMR(100MHz,CDCl3):δ146.0,138.3,133.3,126.5,126.1,124.2,32.0,29.9,22.2,13.6;IR(neat)2957,1593,1566,1456,1436,1304,1251,1061,916,732em-1;HRMS(EI)计算值C10H13NO2S211.0667,实际值211.0666. 
实施例19 
正丁基(3-硝基苯基)硫醚的合成: 
Figure BDA0000462974950000131
在氮气氛围下,于25mL的试管反应器中加入底物2hm(0.2mmol,49.8mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2h(80%)。Rf=0.60(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ8.10-8.09(m,1H),7.98-7.96(m,1H),7.58-7.56(m,1H),7.44-7.40(m,1H),3.00(t,J=7.2Hz,2H),1.71-1.64(m,2H),1.53-1.44(m,2H),0.95(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ148.6,140.5,133.5,129.4,121.9,120.0,32.6,30.7,21.9,13.6;IR(neat)2958,1526,1464,1348,1128,1068,878,750em-1;HRMS(EI)计算值C10H13NO2S211.0667,实际值211.0669. 
实施例20 
正丁基(4-硝基苯基)硫醚的合成: 
Figure BDA0000462974950000132
在氮气氛围下,于25mL的试管反应器中加入底物2im(0.2mmol,49.8mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2i(80%)。Rf=0.60(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ8.10(d,J=8.8Hz,2H),7.29(d,J=8.8,2H),3.00(t,J=7.6Hz,2H),1.73-1.66(m,2H),1.53-1.44(m,2H),0.95(t,J=8.4Hz,3H);13CNMR(100MHz,CDCl3):δ148.1,144.7,125.9,123.8,31.5,30.4,21.9,13.5;IR(neat)2957,1580, 1512,1337,1242,1091,853cm-1;HRMS(EI)计算值C10H13NO2S211.0667,实际值211.0666. 
实施例21 
四氢呋喃甲基(4-三氟甲基苯基)硫醚的合成: 
Figure BDA0000462974950000141
在氮气氛围下,于25mL的试管反应器中加入底物2jm(0.2mmol,54.4mg),2-(氯甲基)四氢呋喃(3.0mmol,360.0mg),PdCl2(dppt)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2j(62%)。Rf=0.3(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ7.50(d,J=8.4Hz,2H),7.40(d,J=8.4Hz,2H),4.13-4.06(m,1H),3.94-3.89(m,1H),3.80-3.75(m,1H),3.21-3.03(m,2H),2.13-1.98(m,1H),1.90-1.85(m,2H),1.73-1.64(m,1H);13C NMR(100MHz,CDCl3):δ142.1,127.5,127.5(q,J2=32.4Hz),127.5,125.6(q,J3=3.8Hz),124.1(q,J1=269.9Hz),77.3,68.4,37.7,31.0,25.8;19F NMR(376MHz,CDCl3):δ-62.4(s,3F);IR(neat)2974,1607,1499,1461,1402,1284,1163,1063,825cm-1;HRMS(EI)计算值C12H13OSF3262.0639,实际值262.0640. 
实施例22 
4-(丁硫基)-3-甲氧基-5-硝基苯甲醛的合成: 
Figure BDA0000462974950000142
在氮气氛围下,于25mL的试管反应器中加入底物2km(0.2mmol,65.8mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3 mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2k(51%)。Rf=0.2(乙酸乙酯∶石油醚=5∶1),1H NMR(400MHz,CDCl3):δ9.96(s,1H),7.75(d,J=1.2Hz,2H),7.52(s,1H),4.04(s,3H),2.97(t,J=7.2Hz,2H),1.48-1.42(m,2H),1.39-1.33(m,2H),0.86(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ189.1,160.9,154.5,135.9,126.8,117.9,110.9,56.8,34.2,31.7,21.6,13.5;IR(neat)296l,1704,1464,1415,1365,1260,1150,918,863,797,694cm-1;HRMS(EI)计算值C12H15NO4S269.0722,实际值269.0724. 
实施例23 
二乙基5-(2-乙氧基乙基硫代)邻苯二甲酸二乙脂的合成: 
Figure BDA0000462974950000151
在氮气氛围下,于25mL的试管反应器中加入底物21m(0.2mmol,74.0mg),1-氯-2-乙氧基乙烷(3.0mmol,324.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.0l mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物21(84%)。Rf=0.30(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ8.26(d,J=0.8Hz,1H),7.77(s,2H),4.37(q,J=7.2Hz,14.4Hz,4H),4.20-4.18(m,2H),3.81-3.79(m,2H),3.62-3.56(m,2H),1.38(t,J=6.8Hz,6H),1.25-1.21(m,3H);13C NMR(100MHz,CDCl3):δ165.6,158.8,132.0,123.0,119.8,68.7,68.0,66.8,61.3,15.1,14.2;IR(neat)2979,1724,1493,1415,1392,1311,1099,1065,797,718,665cm-1;HRMS(EI)计算值C15H2005S326.1188,实际值326.1197. 
实施例24 
2-(2-乙氧基乙基硫基)蒽-9,10-二酮的合成: 
Figure BDA0000462974950000161
在氮气氛围下,于25mL的试管反应器中加入底物2mm(0.2mmol,70.0mg),1-氯-2-乙氧基乙烷(3.0mmol,324.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物2m(73%)。Rf=0.35(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ8.27-8.24(m,2H),8.14(d,J=8.4Hz,1H),8.10(d,J=4.0Hz,1H),7.78-7.75(m,2H),7.62-7.60(m,1H),3.73(t,J=6.4Hz,2H),3.55(q,J=6.8Hz,14.0Hz,2H),3.29(t,J=6.4Hz,2H),1.21(t,J=6.8Hz,3H);13C NMR(100MHz,CDCl3):δ182.9,182.3,146.6,134.2,133.9,133.5,133.2,131.4,130.1,127.6,127.1,127.1,123.7,68.5,66.6,31.7,15.1;IR(neat)2927,1673,1581,1377,1330,1215,1112,1069,933,764cm-1;HRMS(EI)计算值C18H16O3S312.0820,实际值312.0819. 
实施例25 
2-(丁硫基)吡啶的合成: 
Figure BDA0000462974950000162
在氮气氛围下,于25mL的试管反应器中加入底物3aam(0.2mmol,31.4mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3aa(93%)。Rf=0.80(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ8.42-8.41(m,1H),7.48-7.44(m,1H),7.16(d,J=8.0Hz,1H),6.97-6.94(m,1H),3.16(t,J=7.6Hz,2H),1.73-1.65(m,2H),1.52-1.42(m,2H),0.94(t,J=7.6Hz,3H);13C NMR(100MHz,CDCl3):δ159.6,149.3,135.8,122.1,119.1, 31.4,29.8,22.1,13.7;IR(neat)2956,2857,1736,1683,1454,1414,1283,1126,1098,796,691cm-1;HRMS(EI)计算值C9H13NS167.0769,实际值167.0767. 
实施例26 
2-(辛硫基)吡啶的合成: 
Figure BDA0000462974950000171
在氮气氛围下,于25mL的试管反应器中加入底物3abm(0.2mmol,31.4mg),1-氯辛烷(3.0mmol,447.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ab(86%)。Rf=0.70(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ8.40-8.39(m,1H),7.44-7.40(m,1H),7.13(d,J=8.0Hz,1H),6.93-6.90(m,1H),3.13(t,J=7.6Hz,2H),1.72-1.64(m,2H),1.44-1.40(m,2H),1.26-1.24(m,8H),0.86(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ159.5,149.3,135.6,122.0,119.0,31.7,30.0,29.2,29.1,28.9,22.6,14.0;IR(neat)2954,2854,1709,1687,1580,1454,1414,1282,1126,796,757cm-1;HRMS(EI)计算值C13H21NS223.1395,实际值223.1397. 
实施例27 
2-(十八烷硫基)吡啶的合成: 
Figure BDA0000462974950000172
在氮气氛围下,于25mL的试管反应器中加入底物3acm(0.2mmol,31.4mg),氯代十八烷(3.0mmol,864.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL). 将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ac(82%)。Rf=0.50(乙酸乙酯∶石油醚=50∶1),1H NMR(400MHz,CDCl3):δ8.42-8.41(m,1H),7.47-7.43(m,1H),7.15(d,J=8.0Hz,1H),6.96-6.93(m,1H),3.15(t,J=7.2Hz,2H),1.73-1.67(m,2H),1.45-1.40(m,2H),1.13-1.05(m,18H),0.87(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ159.6,149.3,135.8,122.1,119.1,31.1,30.1,29.7,29.6,29.5,29.4,29.3,29.2,29.0,22.7,14.1;IR(neat)3044,2920,2851,1554,1456,1414,1283,1134,1043,758,725cm-1;HRMS(EI)计算值C23H44NS363.2960,实际值363.2961. 
实施例28 
3-((2-乙氧基乙基)硫代)-2-硝基吡啶的合成: 
Figure BDA0000462974950000181
在氮气氛围下,于25mL的试管反应器中加入底物3aem(0.2mmol,54.4mg),2-乙氧基氯乙烷(3.0mmol,324.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ae(85%)。Rf=0.40(乙酸乙酯∶石油醚=5∶1),1H NMR(400MHz,CDCl3):δ8.07(d,J=4.8Hz,1H),7.61-7.59(m,1H),7.52-7.49(m,1H),4.28(t,J=4.8Hz,2H),3.80(t,J=4.4Hz,2H),3.56(q,J=8.0Hz,14.0Hz,2H),1.18(t,J=6.8Hz,3H);13C NMR(100MHz,CDCl3):δ147.3,139.4,128.5,124.5,69.9,68.5,67.1,15.0;IR(neat)2981,2857,1462,1432,1292,1115,1096,1056,858,800,735cm-1;HRMS(EI)计算值C9H12N2O3S228.0570,实际值228.0569. 
实施例29 
4-(丙硫基)吡啶的合成: 
Figure BDA0000462974950000191
在氮气氛围下,于25mL的试管反应器中加入底物3afm(0.2mmol,39.0mg),氯代正丙烷(3.0mmol,234.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3af(64%).Rf=0.25(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ8.26(d,J=6.4Hz,2H),7.09(d,J=6.4Hz,2H),2.94(t,J=7.2Hz,2H),1.78-1.69(m,2H),1.06(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ149.5,149.1,120.6,32.5,21.9,13.4;IR(neat)2961,2872,1739,1482,1407,1242,1048,851,800cm-1;HRMS(EI)计算值C8H11NS153.0612,实际值153.0613. 
实施例30 
2-(2-四氢呋喃甲硫基)吡啶的合成: 
Figure BDA0000462974950000192
在氮气氛围下,于25mL的试管反应器中加入底物3agm(0.2mmol,31.4mg),2-(氯甲基)四氢呋喃(3.0mmol,360.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ag(79%).Rf=0.5(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ8.40(d,J=4.8Hz,1H),7.47-7.43(m,1H),7.19(d,J=8.0Hz,1H),6.97-6.94(m,1H),4.18-4.12(m,1H),3.91(q,J=6.8Hz,14.0Hz,1H),3.77(q,J=7.6Hz,14.4Hz,1H),3.37(d,J=6.4Hz,2H),2.11-2.03(m,1H),1.98-1.83(m,2H),1.73-1.65(m,1H);13C NMR(100MHz,CDCl3):δ158.7,149.3,135.8,122.3,119.3,77.9,68.3,34.6,30.8,25.8;IR(neat)2925,1578,1556,1454,1414,1148,1057,873,805, 759cm-1;HRMS(EI)计算值C10H13NOS195.0718,实际值195.0720. 
实施例31 
4-甲基-2-(2-四氢呋喃甲硫基)吡啶的合成: 
Figure BDA0000462974950000201
在氮气氛围下,于25mL的试管反应器中加入底物3ahm(0.2mmol,34.4mg),2-(氯甲基)四氢呋喃(3.0mmol,360.0mg),PdCl2(dpPf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na282O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ah(64%).Rf=0.60(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ8.27(d,J=3.2Hz,1H),7.03(m,1H),6.80(d,J=4.8Hz,1H),4.17-4.11(m,1H),3.92(q,J=7.2Hz,14.0Hz,1H),3.77(q,J=8.0Hz,14.4Hz,1H),3.36(d,J=6.0Hz,2H),2.26(s,3H),2.10-2.0l(m,1H),2.00-1.84(m,2H),1.72-1.64(m,1H);13C NMR(100MHz,CDCl3):δ158.3,148.9,147.1,122.8,120.8,77.9,68.3,34.6,30.8,25.8,20.8;IR(neat)2975,2868,1546,1466,1445,1371,1223,1121,1057,869,814cm-1;HRMS(EI)计算值C11H15NOS209.0874,实际值209.0878. 
实施例32 
5-甲基-2-(2-四氢呋喃甲硫基)吡啶的合成: 
Figure BDA0000462974950000202
在氮气氛围下,于25mL的试管反应器中加入底物3aim(0.2mmol,34.4mg),2-(氯甲基)四氢呋喃(3.0mmol,360.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用 饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ai(64%).Rf=209.0872(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ8.18(d,J=0.4Hz,1H),7.23-7.20(m,1H),7.04(d,J=8.0Hz,1H),4.10-4.04(m,1H),3.85(q,J=6.8Hz,14.0Hz,1H),3.70(q,J=4.0Hz,14.4Hz,1H),3.28(d,J=6.0Hz,2H),2.18(s,3H),2.03-1.95(m,1H),1.93-1.75(m,2H),1.66-1.57(m,1H);13C NMR(100MHz,CDCl3):δ155.1,149.5,136.9,128.8,121.9,77.9,68.3,34.8,30.8,25.8,17.8;IR(neat)2976,2868,1554,1463,1366,1285,1144,1057,1024,951,918,874,817;HRMS(EI)计算值C11H15NOS209.0874,实际值209.0872. 
实施例33 
5-甲氧基-2-(2-四氢呋喃甲硫基)吡啶的合成: 
在氮气氛围下,于25mL的试管反应器中加入底物3ajm(0.2mmol,37.6mg),2-(氯甲基)四氢呋喃(3.0mmol,360.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3aj(68%).Rf=0.30(乙酸乙酯∶石油醚=5∶1);1H NMR(400MHz,CDCl3):δ8.15(d,J=3.2Hz,1H),7.16(d,J=8.8Hz,1H),7.09-7.06(m,1H),4.15-4.09(m,1H),3.91(q,J=7.6Hz,14.0Hz,1H),3.82(s,3H),3.76(q,J=8.0Hz,14.4Hz,1H),3.32(d,J=6.0Hz,2H),2.09-2.01(m,1H),1.97-1.82(m,2H),1.71-1.63(m,1H);13C NMR(100MHz,CDCl3):δ153.5,149.2,136.3,123.1,122.5,78.0,68.3,55.8,35.7,30.8,25.8;IR(neat)2973,2840,1589,1465,1437,1380,1271,1116,1027,950,914,827,731cm-1;HRMS(EI)计算值C11H15NO28225,0824,实际值225.0822. 
实施例34 
2-(2-四氢呋喃甲硫基)-5-三氟甲基吡啶的合成: 
Figure BDA0000462974950000221
在氮气氛围下,于25mL的试管反应器中加入底物3akm(0.2mmol,45.0mg),2-(氯甲基)四氢呋喃(3.0mmol,360.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ak(75%).Rf=0.60(乙酸乙酯∶石油醚=10∶1),1H NMR(400MHz,CDCl3):δ8.64(s,1H),7.65-7.62(m,1H),7.28(d,J=8.8Hz,1H),4.19-4.12(m,1H),3.92(q,J=7.2Hz,14.4Hz,1H),3.77(q,J=8.0Hz,14.4Hz,1H),3.47-3.36(m,2H),2.12-2.04(m,1H),2.01-1.86(m,2H),1.72-1.63(m,1H);13CNMR(100MHz,CDCl3):δ163.8,146.1(q,J3=4.2Hz),132.4(q,J3=3.2Hz),123.8(q,J1=270.1Hz),122.2(q,J2=33.0Hz),121.7,77.5,68.3,34.6,30.8,25.8;19F NMR(376MHz,CDCl3):δ-62.2(s,3F);IR(neat)2978,2872,1600,1556,1474,1326,1290,1250,1167,1059,938,831,793,747cm-1;HRMS(EI)计算值C11H12NOSF3263.0592,实际值263.0593. 
实施例35 
2-(5-(三氟甲基)吡啶硫代)乙醇的合成: 
在氮气氛围下,于25mL的试管反应器中加入底物3alm(0.2mmol,45.0mg),2-氯乙醇(3.0mmol,240.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3al(62%).Rf=0.20(乙酸乙酯∶石油醚=5∶1);1H NMR(400MHz,CDCl3):δ8.62(s,1H),7.69-7.66(m,1H),7.34(d,J=7.6Hz,1H),3.93(t,J=5.6Hz,2H),3.54(s,1H),3.39(t,J=5.6Hz,2H);13C NMR(100MHz, CDCl3):δ163.8,145.9(q,J3=4.3Hz),132.9(q,J3=3.1Hz),123.5(q,J1=270.1Hz),122.8(q,J2=33.4Hz),122.1,62.6,33.5;19F NMR(376MHz,CDCl3):δ-62.3(s,3F);IR(neat)2962,2860,2353,1740,1603,1472,1330,1260,1090,864,798cm-1;HRMS(EI)计算值C8H8F3NOS223.0279,实际值223.0277. 
实施例36 
2-(叔丁基二甲基硅氧基)乙硫基-5-三氟甲基吡啶的合成: 
Figure BDA0000462974950000231
在氮气氛围下,于25mL的试管反应器中加入底物3amm(0.2mmol,45.0mg),叔丁基(2-氯乙氧基)二甲基硅烷(3.0mmol,582.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3am(98%).Rf=0.80(乙酸乙酯∶石油醚=50∶1),1H NMR(400MHz,CDCl3):δ8.64(s,1H),7.66-7.63(m,1H),7.27(d,J=7.6Hz,1H),3.86(t,J=6.8Hz,2H),3.37(t,J=6.8Hz,2H),0.90(s,9H),0.08(s,6H);13C NMR(100MHz,CDCl3):δ163.9,146.1(q,J3=4.3Hz),132.4(q,J3=3.4Hz),123.8(q,J1=269.8Hz),122.2(q,J2=32.9Hz),121.1,62.1,32.3,25.9,18.3,-5.3;19FNMR(376MHz,CDCl3):δ-62.2(s,3F);IR(neat)2954,2859,1602,1472,1378,1254,1168,1132,1008,959,837,778cm-1;HRMS(EI)计算值C14H22F3NOSSi337.1143,实际值337.1149. 
实施例37 
2-苯乙基硫甲基吡啶的合成: 
Figure BDA0000462974950000232
在氮气氛围下,于25mL的试管反应器中加入底物3anm(0.2mmol,31.4mg),2-氯乙基苯 (3.0mmol,420.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg)DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3an(77%).Rf=0.70(乙酸乙酯∶石油醚=50∶1),1H NMR(400MHz,CDCl3):δ7.39-7.37(m,1H),7.25-7.08(m,6H),6.91-6.88(m,1H),3.35(t,J=8.0Hz,2H),2.94(t,J=7.6,3H);13C NMR(100MHz,CDCl3):δ158.9,149.4,140.5,135.9,128.6,128.4,126.3,122.4,119.3,35.8,31.4;IR(neat)3028,1603,1556,1496,1454,1414,1282,1125,1073,930,834,757,698cm-1;HRMS(EI)计算值C13H13NS215.0769,实际值215.0770. 
实施例38 
2-(叔丁基二甲基硅氧基)乙硫基吡啶的合成: 
在氮气氛围下,于25mL的试管反应器中加入底物3aom(0.2mmol,31.4mg),叔丁基(2-氯乙氧基)二甲基硅烷(3.0mmol,582.0mg),PdCl2(dppt)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ao(62%).Rf=0.70(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ8.40-8.39(m,1H),7.46-7.42(m,1H),7.17(d,J=8.0Hz,1H),6.96-6.93(m,1H),3.85(t,J=7.6Hz,2H),3.32(t,J=7.6Hz,2H);13C NMR(100MHz,CDCl3):δ158.7,149.3,135.8,122.1,119.3,62.5,32.1,25.9,18.3,-5.3;IR(neat)2952,2857,1580,1455,1415,1390,1362,1254,1032,893,837,758cm-1;HRMS(EI)计算值C13H23NOSSi269.1270,实际值269.1266. 
实施例39 
2-醛基-5-丁硫基呋喃的合成: 
Figure BDA0000462974950000251
在氮气氛围下,于25mL的试管反应器中加入底物3bam(0.2mmol,56.0mg),氯代正丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na282O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ba(85%).Rf=0.60(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ9.49(s,1H),7.21(d,J=3.6Hz,1H),6.46(d,J=3.6Hz,1H),3.00(t,J=7.2Hz,2H),1.68-1.60(m,2H),1.45-1.38(m,2H),0.91(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ176.1,156.5,153.9,123.0,113.7,33.4,31.6,21.6,13.5;IR(neat)2961,1562,1452,1345,1275,1193,1023,959,875,762cm-1;HRMS(EI)计算值C9H12O2S184.0558,实际值184.0560. 
实施例40 
2-醛基-5-仲丁硫基呋喃的合成: 
Figure BDA0000462974950000252
在氮气氛围下,于25mL的试管反应器中加入底物3bbm(0.2mmol,56.0mg),仲丁基氯(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3bb(58%).Rf=0.60(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ9.53(s,1H),7.20(d,J=3.6Hz,1H),6.45(d,J=3.2Hz,1H),3.36-3.27(m,1H),1.71-1.55(m,2H),1.31(d,J=6.8Hz,3H),1.00(t,J=7.6Hz,3H);13C NMR(100MHz,CDCl3):δ176.5,155.1,154.3,122.4,116.7,46.2,29.9,21.1,11.3;IR(neat)2968,1562,1453,1344,1276,1192,1150,1058,1021,961,802,762cm-1;HRMS (EI)计算值C9H12O2S184.0558,实际值184.0559. 
实施例41 
2-醛基5-(2-乙基甲硫基)呋喃的合成: 
Figure BDA0000462974950000261
氛围下,于25mL的试管反应器中加入底物3bcm(0.2mmol,56.0mg),1-氯-2乙基乙醚(3.0mmol,324.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3bc(60%).Rf=0.25(乙酸乙酯∶石油醚=10∶1),1H NMR(400MHz,CDCl3):δ9.48(s,1H),7.18(d,J=3.6Hz,1H),6.49(d,J=3.6Hz,1H),3.64(t,J=6.4Hz,2H),3.48(q,J=7.2Hz,14.0Hz,2H),3.12(t,J=6.0Hz,2H),1.15(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ176.1,155.5,153.9,122.9,114.2,69.0,66.4,33.4,15.0;IR(neat)2979,2339,2321,1536,1377,1280,1241,1195,1161,1022,960,935,800,762cm-1;HRMS(EI)计算值C9H12O3S200.0507,实际值200.0506. 
实施例42 
2-醛基5-(2-苯硫基乙硫基)呋喃的合成: 
在氮气氛围下,于25mL的试管反应器中加入底物3bdm(0.2mmol,56.0mg),2-氯乙基苯硫醚(3.0mmol,516.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3bd(76%). Rf=0.40(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ9.52(s,1H),7.36-7.28(m,4H),7.24-7.19(m,2H),6.49(d,J=3.6,1H),3.16(s,4H);13C NMR(100MHz,CDCl3):δ176.3,154.4,154.2,134.4,130.1,129.2,126.8,122.7,115.0,34.0,33.2;IR(neat)2924,2854,2361,1717,1676,1581,1454,1378,1280,1206,1022,762,792cm-1;HRMS(EI)计算值C13H12O2S2264.0279,实际值264.0274. 
实施例43 
2-醛基-5-环丙基甲硫基呋喃-的合成: 
Figure BDA0000462974950000271
在氮气氛围下,于25mL的试管反应器中加入底物3bem(0.2mmol,56.0mg),1-氯甲基环丙烷(3.0mmol,270.0mg),PdCl2(dpPf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na282O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3be(80%).Rf=0.35(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ9.50(s,1H),7.20(d,J=3.6Hz,1H),6.49(d,J=3.6Hz,1H),2.94(d,J=12.0Hz,2H),1.09-1.02(m,1H),0.60-0.56(m,2H),0.24-0.17(m,2H);13C NMR(100MHz,CDCl3):δ176.2,156.3,153.8,123.1,114.2,39.8,11.1,5.7;IR(neat)3136,2926,2814,1723,1673,1561,1451,1378,1245,1193,1021,961,761,730cm-1;HRMS(EI)计算值C9H10O2S182.0403,实际值182.0403. 
实施例44 
2-醛基-5-环戊硫基呋喃的合成: 
Figure BDA0000462974950000272
在氮气氛围下,于25mL的试管反应器中加入底物3bfm(0.2mmol,56.0mg),环戊基氯(3.0mmol,312.0mg),PdCl2(dpPf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3bf(63%).Rf=0.50(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ9.52(s,1H),7.20(d,J=3.6Hz,1H),6.49(d,J=3.6Hz,1H),3.74-3.67(m,1H),2.10-2.01(m,2H),1.81-1.71(m,2H),1.66-1.60(m,4H);13C NMR(100MHz,CDCl3):δ176.4,156.6,154.0,122.8,114.9,46.9,33.7,24.6;IR(neat)2954,2868,1724,1676,1562,1453,1378,1277,1212,1192,1022,961,762,659cm-1;HRMS(EI)计算值C10H12O2S196.0558,实际值196.0560. 
实施例45 
2-醛基-5-环庚硫基呋喃的合成: 
在氮气氛围下,于25mL的试管反应器中加入底物3bgm(0.2mmol,56.0mg),环庚基氯(3.0mmol,396.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ag(53%)..Rf=0.50(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ9.53(s,1H),7.21(d,J=3.2Hz,1H),6.53(d,J=3.6Hz,1H),3.55-3.48(m,1H),2.06-1.99(m,2H),1.74-1.44(m,l1H);13C NMR(100MHz,CDCl3):δ176.5,155.8,154.2,122.6,116.3,49.3,35.1,28.1,25.6;IR(neat)2928,1740,1679,1562,1454,1379,1259,1192,1020,962,799,762cm-1;HRMS(EI)计算值C12H16O2S224.087l,实际值224.0872. 
实施例46 
2-醛基-5-环辛硫基呋喃的合成: 
Figure BDA0000462974950000291
在氮气氛围下,于25mL的试管反应器中加入底物3bhm(0.2mmol,56.0mg),chlorocyclooctane(3.0mmol,438.0mg),PdCl2(dppt)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)andglycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3bh(62%).Rf=0.55(乙酸乙酯∶石油醚=10∶1),1H NMR(400MHz,CDCl3):δ9.53(s,1H),7.20(d,J=3.2Hz,1H),6.53(d,J=3.6Hz,1H),3.61-3.56(m,1H),2.00-1.93(m,2H),1.76-1.64(m,4H),1.59-1.50(m,8H);13C NMR(100MHz,CDCl3):δ176.6,155.8,154.2,122.6,116.3,49.1,32.2,27.0,25.6,24.9;IR(neat)2922,1727,1679,1561,1450,1379,1314,1259,1192,1088,1020,961,762,664cm-1;HRMS(EI)计算值C13H18O2S238.1028,实际值238.1027. 
实施例47 
2-乙酰基-5-乙氧基乙基硫基噻吩的合成: 
Figure BDA0000462974950000292
在氮气氛围下,于25mL的试管反应器中加入底物3cam(0.2mmol,40.8mg),l-氯-2-乙基乙醚(3.0mmol,324.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3ca(82%).Rf=0.40(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ7.51(d,J=4.0Hz,1H),7.01(d,J=4.0Hz,1H),3.64(t,J=6.4Hz,2H),3.51(q,J=6.8Hz,14.0Hz,2H),3.12(t,J=6.4Hz,2H),2.46(s,3H),1.18(t,J=6.8Hz,3H);13C NMR(100MHz,CDCl3):δ189.6,146.9,144.8,132.7,130.4,68.6,66.5,36.9,26.3,15.0;IR(neat)2980,1658,1413,1359,1315,1275,1237,1126, 1104,997,925,797cm-1;HRMS(EI)计算值C10H14O2S2230.0435,实际值230.0436. 
实施例48 
2-醛基-5-(2-乙基甲硫基)噻吩的合成: 
在氮气氛围下,于25mL的试管反应器中加入底物3cbm(0.2mmol,38.0mg),1-氯-2-乙基乙醚(3.0mmol,324.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3cb(68%).Rf=0.30(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ9.75(s,1H),7.60(d,J=3.6Hz,1H),7.08(d,J=4.0Hz,1H),3.67(t,J=6.4Hz,2H),3.51(q,J=7.2Hz,14.0Hz,2H),3.17(t,J=6.8Hz,2H),1.19(t,J=6.8Hz,3H);13C NMR(100MHz,CDCl3):δ181.6,148.7,143.6,136.8,129.5,68.5,66.6,36.8,15.0;IR(neat)2977,1758,1666,1518,1415,1377,1295,1106,1010,996,800,750,668cm-1;HRMS(EI)计算值C9H12O2S2216.0279,实际值216.0278. 
实施例49 
2-乙氧基乙基硫代-5-(N-甲基-N-苯基甲酰胺)噻吩的合成: 
在氮气氛围下,于25mL的试管反应器中加入底物3ccm(0.2mmol,59.0mg),1-氯-2-乙基乙醚(3.0mmol,324.0mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,l95.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3cc(76%).Rf=0.20(乙酸乙酯∶石油醚= 10∶1);1H NMR(400MHz,CDCl3):δ7.41-7.35(m,3H),7.23-7.21(m,3H),6.73(d,J=4.0Hz,1H),6.60(d,J=4.0Hz,1H),3.50(t,J=6.4Hz,2H),3.46-3.40(m,5H),2.91(t,J=6.4Hz,2H),1.15(t,J=6.8Hz,3H);13C NMR(100MHz,CDCl3):δ161.8,143.8,141.1,139.6,132.4,131.1,129.7,128.2,128.0,68.6,66.3,38.9,37.2,15.0;IR(neat)2977,1737,1628,1593,1495,1423,1371,1290,1160,1102,1047,968,811,775,700cm-1;HRMS(EI)计算值C16H19NO2S2321.0857,实际值321.0856. 
实施例50 
2-乙氧基乙基硫代-5-丙烯基乙脂噻吩的合成: 
Figure BDA0000462974950000311
在氮气氛围下,于25mL的试管反应器中加入底物3cdm(0.2mmol,52.0mg),1-氯-2-乙基乙醚(3.0mmol,324.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3cd(68%).Rf=0.60(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ7.64(d,J=8.0Hz,1H),7.07(d,J=3.6Hz,1H),7.01(d,J=4.0Hz,1H),6.13(d,J=15.6Hz,1H),4.23(q,J=7.2Hz,14.0Hz,2H),3.62(t,J=6.4Hz,2H),3.50(q,J=7.2Hz,14.0Hz,2H),3.03(t,J=6.8Hz,2H),1.31(t,J=7.2,3H),1.19(t,J=6.8Hz,3H);13C NMR(100MHz,CDCl3):δ166.6,141.9,139.1,136.4,132.9,131.2,117.1,68.8,66.5,60.5,37.6,15.1,14.3;IR(neat)2980,1742,1624,1426,1370,1337,1302,1259,1162,1097,1018,969,799,733,670em-1;HRMS(EI)计算值C13H18O3S2286.0697,实附值286.0700. 
实施例51 
2-氯-3-(丙硫基)吡嗪的合成: 
在氮气氛围下,于25mL的试管反应器中加入底物3dam(0.2mmol,29.6mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dpPf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na282O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3da(88%).Rf=0.8(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ8.29(d,J=2.8Hz,1H),7.98(d,J=2.4Hz,1H),3.16(t,J=7.2Hz,2H),1.74-1.66(m,2H),1.53-1.44(m,2H),0.95(t,J=7.6Hz,3H); 13C NMR(100MHz,CDCl3):δ157.0,146.3,141.6,137.4,30.8,30.0,22.1,13.6;IR(neat)2961,1498,1431,1338,1260,1146,1094,1053,1019,845,798,691cm-1;HRMS(EI)计算值C8H11ClN2S202.0331,实际值202.0334. 
实施例52 
2,6-二(丁硫基)吡啶的合成: 
Figure BDA0000462974950000322
在氮气氛围下,于25mL的试管反应器中加入底物3dbm(0.2mmol,47.0mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3db(41%).Rf=0.6(Ethyl Acetate∶Petroleum Ether=10∶1),1H NMR(400MHz,CDCl3):δ7.23(t,J=8.0Hz,1H),6.83(d,J=8.0Hz,2H),3.17(t,J=7.6Hz,4H),1.74-1.66(m,2H),1.51-1.40(m,2H),0.94(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ158.8,135.6,117.3,31.8,29.6,22.1,13.7;IR(neat) 2958,2870,1716,1548,1462,1412,1378,1259,1142,1095,799,743,722cm-1;HRMS(EI)计算值C13H21NS2255.1115,实际值255.1113. 
实施例53 
N-(2-(5-三氟甲基吡啶-2-基硫基)乙基)邻苯二甲酰胺的合成: 
在氮气氛围下,于25mL的试管反应器中加入底物3dcm(0.2mmol,45.0mg),3dcm’(1.0mmol,209.0mg),PdCl2(dppt)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3dc(61%).Rf=0.30(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ8.57(s,1H),7.83-7.69(m,2H),7.64-7.61(m,2H),7.64-7.61(m,1H),7.25(d,J=8.8,1H),4.07(t,J=6.4,1H),3.55(t,J=6.4,1H);13C NMR(100MHz,CDCl3):δ168.1,162.7,146.2(q,J3=4.1Hz),134.0,132.6(q,J3=3.4Hz),132.0,123.7(q,J1=269.7Hz),123.2,122.5(q,J2=33.3Hz),121.7,37.3,28.3.19F NMR(376MHz,CDCl3):δ-62.2(s,3F);IR(neat)1772,1598,1557,1469,1434,1393,1324,1250,1168,1117,1009,977,934,833,793,717em-1;HRMS(EI)计算值C16HnN2O2SF3352.0493,实际值352.0492. 
实施例54 
2-(丁硫基)苯并呋喃的合成: 
Figure BDA0000462974950000332
在氮气氛围下,于25mL的试管反应器中加入底物3ddm(0.2mmol,48.8mg),1-chlorobutane(3.0mmol,276.0mg),PdCl2(dppt)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6 mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)andglycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3dd(79%).Rf=0.80(乙酸乙酯∶石油醚=100∶1);1H NMR(400MHz,CDCl3):δ7.42-7.40(m,2H),7.36(d,J=8.0,1H),7.20-7.09(m,2H),6.69(s,1H),2.86(t,J=7.2Hz,2H),1.60-1.52(m,2H),1.41-1.31(m,2H),0.83(t,J=7.6Hz,3H);13C NMR(100MHz,CDCl3):δ156.2,150.8,128.6,124.2,122.8,120.2,110.9,110.6,34.3,31.8,21.6,13.6;IR(neat)2959,2856,1784,1650,1588,1445,1380,1302,1257,1230,1145,1086,925,798,748cm-1;HRMS(EI)计算值C12H14OS206.0765,实际值206.0766. 
实施例55 
2-(丙硫基)苯并噻吩的合成: 
Figure BDA0000462974950000341
在氮气氛围下,于25mL的试管反应器中加入底物3dem(0.2mmol,52.0mg),1-氯丙烷(3.0mmol,234.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3de(63%).Rf=0.80(乙酸乙酯∶石油醚=50∶1);1H NMR(400MHz,CDCl3):δ7.64(d,J=7.6,1H),7.59-7.57(m,1H),7.25-7.15(m,3H),2.82(t,J=7.2Hz,2H),1.66-1.57(m,2H),0.93(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ141.5,139.8,137.6,127.7,124.4,124.2,122.9,121.8,39.5,22.8,13.1;IR(neat)3060,2961,1456,1424,1338,1324,1297,1237,1131,1068,970,799,744cm-1;HRMS(EI)计算值C11H12S2208.0380,实际值208.0381. 
实施例56 
2-(丁硫基)苯并噻唑的合成: 
在氮气氛围下,于25mL的试管反应器中加入底物3dfm(0.2mmol,52.0mg),1-氯丁烷(3.0mmol,276.0mg),PdCl2(dppf)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3df(62%).Rf=0.80(乙酸乙酯∶石油醚=10∶1),1H NMR(400MHz,CDCl3):δ7.87(d,J=8.0,1H),7.75(d,J=8.0,1H),7.43-7.39(m,1H),7.30-7.26(m,1H),3.35(t,J=7.6Hz,2H),1.85-1.77(m,2H),1.56-1.47(m,2H),0.97(t,J=11.6Hz,3H);13C NMR(100MHz,CDCl3):δ167.4,153.4,135.1,126.0,124.1,121.4,120.9,33.3,31.2,21.9,13.6;IR(neat)2956,2871,1742,1461,1428,1374,1259,1083,1018,995,798,682cm-1;HRMS(EI)计算值C11H13NS2223.0489,实际值223.0481. 
实施例57 
2-乙氧基乙基硫代苯并恶唑的合成: 
Figure BDA0000462974950000352
在氮气氛围下,于25mL的试管反应器中加入底物3dgm(0.2mmol,49.0mg),1-氯-2乙基乙醚(3.0mmol,324.0mg),PdCl2(dppt)(0.02mmol,14.6mg),DPPF(0.01mmol,5.6mg),Cs2CO3(0.3mmol,195.0mg),Na2S2O3·5H2O(0.5mmol,248.0mg),DMSO(4.0mL)and glycol(0.1mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3dg(60%).Rf=0.40(乙酸乙酯∶石油醚=10∶1),1H NMR(400MHz,CDCl3):δ7.19-7.06(m,4H),3.99(t,J=5.6Hz,2H),3.72(t,J=4.8Hz,2H),3.48(q,J=7.2Hz,14.0Hz,2H),1.12(t,J=7.2Hz,3H); 13C NMR(100MHz,CDCl3):δ154.6,142.6,131.7,123.6,122.2,109.7,109.4,67.9,66.6,42.6,15.0;IR(neat)2974,2868,1768,1614,1486,1392,1258,1156,1011,952,872,798cm-1;HRMS (EI)计算值C11H13NO2S223.0667,实际值223.0671. 
实施例58 
4-丁硫基-N-甲基-N-(5-甲基异恶唑)苯磺酰胺的合成: 
Figure BDA0000462974950000361
在氮气氛围下,于25mL的试管反应器中加入底物5am(0.1mmol,37.8mg),1-氯乙基乙醚(1.5mmol,162.0mg),PdCl2(dppf)(0.01mmol,7.3mg),DPPF(0.005mmol,2.8mg),Cs2CO3(0.15mmol,97.5mg),Na2S2O3·5H2O(0.25mmol,124.0mg),DMSO(2.0mL)and glycol(0.05mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物5a(58%).Rf=0.50(乙酸乙酯∶石油醚=10∶1);1H NMR(400MHz,CDCl3):δ7.59(d,J=9.2Hz,2H),7.34(d,J=8.8Hz,2H),6.47(s,1H),3.66(t,J=6.8Hz,2H),3.51(q,J=5.6Hz,14.0Hz,2H),3.25(s,3H),3.17(t,J=6.8Hz,2H),2.38(s,3H),1.19(t,J=7.2Hz,3H);13C NMR(100MHz,CDCl3):δ170.4,160.7,145.4,132.9,127.5,126.8,97.5,68.6,35.1,31.7,15.1,12.6;IR(neat)1713,1613,1579,1481,1446,1408,1360,1221,1173,1078,1059,920,854,800,756,681cm-1;HRMS(EI)计算值C15H20N2O4S2356.0865,实际值356.0862. 
实施例59 
2-(2-甲基-5-硝基-1H-咪唑)乙硫基-5-三氟甲基吡啶的合成: 
Figure BDA0000462974950000362
在氮气氛围下,于25mL的试管反应器中加入底物5bm(0.1mmol,22.5mg),5bm’(1.5mmol,283.5mg),PdCl2(dppf)(0.01mmol,14.6mg),DPPF(0.005mmol,5.6mg),Cs2CO3(0.15mmol,97.5mg),Na2S2O3·5H2O(0.25mmol,124.0mg)DMSO(2.0mL)and glycol(0.05mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵 水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物3b(71%).Rf=0.25(乙酸乙酯∶石油醚=10∶1),1H NMR(400MHz,CDCl3):δ8.63(s,1H),7.89(s,1H),7.71-7.69(m,1H),7.28(t,J=8.4Hz,2H),4.64(t,J=6.8Hz,2H),3.61(t,J=6.8Hz,2H),2.54(s,3H);13CNMR(100MHz,CDCl3):δ161.9,150.8,146.2(q,J3=4.3Hz),133.1(q,J3=3.4Hz),138.6,132.9,123.5(q,J1=270.2Hz),123.1(q,J2=33.1Hz),121.9,45.6,29.1,13.4;19F NMR(376MHz,CDCl3):δ-62.2(s,3F);IR(neat)3413,2952,1742,1632,1599,1528,1467,1425,1364,1260,1186,1120,1076,796,741em-1;HRMS(EI)计算值C12H11F3N4O2S332.0555,实际值332.0554. 
实施例60 
氨基酸衍生物5c的合成: 
Figure BDA0000462974950000371
在氮气氛围下,于25mL的试管反应器中加入底物5cm(0.1mmol,38.2mg),1-chloro-2-ethoxyethane(1.5mmol,162.0mg),PdCl2(dppf)(0.01mmol,7.3mg),DPPF(0.005mmol,2.8mg),Cs2CO3(0.15mmol,97.5mg),Na2S2O3·5H2O(0.25mmol,124.0mg),DMSO(2.0mL)and glycol(0.05mL).将反应体系加热至120℃进行反应。TLC检测反应结束后,将体系冷却至室温。用饱和氯化铵水溶剂淬灭反应,并用乙酸乙酯萃取(3*10mL),柱层析纯化得到产物5c(49%).Rf=0.30(乙酸乙酯∶石油醚=10∶1),1H NMR(400MHz,CDCl3):δ7.30-7.26(m,4H),7.14-7.12(m,1H),7.03(d,J=4.0Hz,1H),6.36(d,J=7.6Hz,1H),5.02-4.97(m,1H),4.20(q,J=6.8Hz,14.0Hz2H),3.62(t,J=6.4Hz,2H),3.51(q,J=1.6Hz,5.2Hz,2H),3.23-3.22(m,2H),3.06(t,J=6.4Hz,2H),1.27(t,J=7.2Hz,3H),1.20(t,J=7.2Hz,3H);13CNMR(100MHz,CDCl3):δ171.4,160.5,141.5,139.8,135.7,132.2,129.4,128.6,128.6,127.2,68.7,66.5,61.7,53.4,38.0,37.6,15.1,14.1;IR(neat)2926,1739,1630,1539,1499,1454,1444,1420,1375,1326,1286,1200,1126,1106,816,744,701cm-1;HRMS(EI)计算值C20H25NO4S2407.1225,实际值407.1227。

Claims (10)

1.一种芳基硫醚类化合物的合成方法,其特征在于,以芳基碘化物或芳基三氟甲烷磺酸酯类衍生物,与卤代烷烃为反应原料,以Na2S2O3为硫化试剂,在钯催化剂作用下,在反应溶剂中反应得到如式(3)所示的芳基硫醚类化合物;所述反应过程如反应式(I)所示;
其中,R是苯环、杂环、取代苯环、或取代杂环;
R’是氢、卤素、杂原子、烷基、或杂环;
X是I、Br、Cl或OTf;
Y是Cl。
2.如权利要求1所述的芳基硫醚类化合物的合成方法,其特征在于,所述钯催化剂是Pd(OAc)2、PdCl2、Pd(TFA)2、Pd(dba)2、Pd2(dba)3、PdCl2(dpPf)或PdCl2(dppp);所述催化剂的用量为1-10%。
3.如权利要求1所述的芳基硫醚类化合物的合成方法,其特征在于,所述配体是PPh3、PtBu3、三环己基膦、三呋喃基膦、1,1-双(二苯基膦)甲烷、1,2-双(二苯基膦)乙烷、1,3-双(二苯基膦)丙烷、1,4-双(二苯膦基)丁烷、1,1′-双(二苯基膦)二茂铁或2,2′-双二苯膦基-1,1′-联萘;所述配体用量为1-5%。
4.如权利要求1所述的芳基硫醚类化合物的合成方法,其特征在于,所述添加剂为水、乙醇、甲醇、乙二醇或环己二醇。
5.如权利要求1所述的芳基硫醚类化合物的合成方法,其特征在于,所述碱为K2CO3、Cs2CO3、K3PO4、NaOAc、三乙胺或4,4-二甲氨基吡啶。
6.如权利要求1所述的芳基硫醚类化合物的合成方法,其特征在于,所述反应溶剂是甲苯、DMSO、DMA、DMF、1,2-二氯乙烷、THF或乙腈。
7.如权利要求1所述的芳基硫醚类化合物的合成方法,其特征在于,所述合成反应在120-150℃进行。
8.如权利要求1所述的芳基硫醚类化合物的合成方法,其特征在于,所述反应为原料芳基碘化物或芳基三氟甲烷磺酸酯类衍生物与所述硫化试剂Na2S2O3的比例为1∶1-1∶5。
9.如权利要求1所述的芳基硫醚类化合物的合成方法,其特征在于,所述反应原料芳基碘化物或芳基三氟甲烷磺酸酯类衍生物和所述卤代烷烃的用量比例为1∶1-1∶15。
10.如权利要求1合成方法制备得到的式(3)所示的芳基硫醚类化合物。
CN201410041032.6A 2014-01-27 2014-01-27 一种芳基硫醚类化合物的合成方法 Active CN103848767B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410041032.6A CN103848767B (zh) 2014-01-27 2014-01-27 一种芳基硫醚类化合物的合成方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410041032.6A CN103848767B (zh) 2014-01-27 2014-01-27 一种芳基硫醚类化合物的合成方法

Publications (2)

Publication Number Publication Date
CN103848767A true CN103848767A (zh) 2014-06-11
CN103848767B CN103848767B (zh) 2016-08-17

Family

ID=50856930

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410041032.6A Active CN103848767B (zh) 2014-01-27 2014-01-27 一种芳基硫醚类化合物的合成方法

Country Status (1)

Country Link
CN (1) CN103848767B (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104045589A (zh) * 2014-05-07 2014-09-17 华东师范大学 一种芳基烷基硫醚化合物及其合成方法
CN105153078A (zh) * 2015-07-16 2015-12-16 华南理工大学 一种硫代氧杂环烷烃化合物及其合成方法
CN112010723A (zh) * 2020-08-29 2020-12-01 湖南理工学院 一种制备二芳基甲基取代硫醚的新方法
CN112047902A (zh) * 2020-09-21 2020-12-08 上海大学 非对称二硫醚类化合物的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060178407A1 (en) * 2004-10-29 2006-08-10 Rigel Pharmaceutical, Inc. Substituted pyridines and their uses
WO2007114902A2 (en) * 2006-04-04 2007-10-11 H.Lundbeck A/S Alkylthiobenzylpiperidine compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060178407A1 (en) * 2004-10-29 2006-08-10 Rigel Pharmaceutical, Inc. Substituted pyridines and their uses
WO2007114902A2 (en) * 2006-04-04 2007-10-11 H.Lundbeck A/S Alkylthiobenzylpiperidine compounds

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ZONGJUN QIAO ET AL.: "Efficient Access to 1,4-benzothiazine:Palladium-Catalyzed Double C-S Bond Formation Using Na2S2O3 as Sulfurating Reagent", 《ORGANIC LETTERS》 *
朱萍等: "正丁基苯并噻唑硫醚萃取分离钯、铂的研究", 《稀有金属》 *
王浩龙等: "以羰基磷氧化物为配体的铜催化的C-S偶联反应", 《催化学报》 *
王浩龙等: "以羰基磷氧化物为配体的铜催化的C-S偶联反应", 《催化学报》, vol. 32, no. 7, 31 December 2011 (2011-12-31), pages 1131 - 1 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104045589A (zh) * 2014-05-07 2014-09-17 华东师范大学 一种芳基烷基硫醚化合物及其合成方法
CN104045589B (zh) * 2014-05-07 2016-08-24 华东师范大学 一种芳基烷基硫醚化合物及其合成方法
CN105153078A (zh) * 2015-07-16 2015-12-16 华南理工大学 一种硫代氧杂环烷烃化合物及其合成方法
CN112010723A (zh) * 2020-08-29 2020-12-01 湖南理工学院 一种制备二芳基甲基取代硫醚的新方法
CN112047902A (zh) * 2020-09-21 2020-12-08 上海大学 非对称二硫醚类化合物的制备方法
CN112047902B (zh) * 2020-09-21 2022-11-18 上海大学 非对称二硫醚类化合物的制备方法

Also Published As

Publication number Publication date
CN103848767B (zh) 2016-08-17

Similar Documents

Publication Publication Date Title
JP5381718B2 (ja) ハロ多環芳香族化合物及びその製造方法
Liu et al. A highly efficient and recyclable ligand-free protocol for the Suzuki coupling reaction of potassium aryltrifluoroborates in water
Yang et al. An unprecedented Pd-catalyzed trans-addition of boronic acids to ynamides
CN103848767A (zh) 一种芳基硫醚类化合物的合成方法
CN103787802B (zh) 一类芳基烷基硫醚化合物及其合成方法
CN108640869B (zh) 过渡金属催化的c-h偶联高效制备邻酰胺化芳基杂环类衍生物
Yang et al. Efficient synthesis of chiral biaryls via asymmetric Suzuki-Miyaura cross-coupling of ortho-bromo aryl triflates
Xu et al. The Chan-Evans-Lam N-arylation of phosphonic/phosphinic amides
CA2455842A1 (en) Process for the preparation of indole derivatives
CN111253305B (zh) 一种烷基取代氮杂芳烃的烯基化或烷基化反应方法
CN110117237B (zh) 一种芳香腈或烯基腈类化合物的制备方法
Nakada et al. Palladium-catalyzed Carboboration: Borylative Coupling of Alkynes with Alkenes through Activation of Boron–Chlorine Bonds
CN111187298B (zh) 一种c2-膦酰基亚甲基吲哚化合物及其制备方法和用途
Iranpoor et al. 1, 3, 2, 4-Diazadiphosphetidines as ligand and base for palladium-catalyzed Suzuki–Miyaura, Sonogashira–Hagihara, and homocoupling reactions of aryl halides under heterogeneous conditions in water
Pawar et al. Sodium 2-(2-pyridin-3-ylethylamino) ethyl sulfonate: an efficient ligand and base for palladium-catalyzed Suzuki reaction in aqueous media
CN103102329B (zh) 一种2,3-二氢-[1,4]-苯并噻嗪类化合物的合成方法
Tanaka et al. Generation of metalated thiophenes with Grignard reagent and catalytic secondary amine for the cross coupling reaction with aryl halides
Ding et al. Organocatalytic Domino Michael/cyclization for the synthesis of highly substituted 4, 5-dihydrothiophenes
WO2015115519A1 (ja) ビピリジル化合物
CN105622537A (zh) 一种3,4,5-三取代异恶唑类化合物的合成方法
CN1332944C (zh) 氨基酸促进的CuI催化的芳基卤化物和烃基亚磺酸盐的偶联反应
Bheeter et al. Palladium-catalysed direct heteroarylation of bromobenzenes bearing SO 2 R substituents at C2 or C4
Gu et al. A mild and efficient amidation of cyclic ethers catalyzed by rhodium caprylate
CN102702069B (zh) 2-氰基取代吲哚化合物及其合成方法
Li et al. Highly Catalytic Activity of Bis (alkoxo) palladium Complexes for Fujiwara-Moritani Reaction

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant